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Abstract 
5'-upstream region of the phospholipase C-β2 gene,
810 bp, was cloned and characterized. S1 nuclease
mapping and primer extension analyses revealed
that a single transcriptional start site locates at 284
nucleotides upstream from the beginning of transla-
tion. The 5'-upstream region lacks both TATA motif
and typical initiator sequence, but retains GC-rich
segment. Two putative regulatory regions, a nega-
tive region (−636/−588) and a positive region (−98/
−13) were identified in the upstream region of PLC-
β2 gene. We suggest that the transcription of PLC-β2
may be regulated by binding of regulatory proteins
to the negative and/or positive regulatory regions
located in the upstream of the gene. 
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Introduction
Phosphoinositide-specific phospholipase Cs (PLCs)
mediate signals from the outside of the cells to various
compartments of the cells. The enzymes catalyze the
hydrolysis of phosphoinositol 4,5-bisphosphate (PIP2) to
two second messengers, inositol 1,4,5-trisphosphate
(IP3) and diacylglycerol (DAG) (Berridge, 1993). To date
11 distinct PLC isozymes are identified in mammalian
tissues and cells. The PLCs were divided into four
types, PLC-β, γ, δ and ε (Kelley et al., 2001). Each type
is composed of more than two subtypes. PLC-β sub-
types appear to have unique tissue distributions. PLC-
β1 was detected in brain, while PLC-β3 was found in a
variety of tissues and cell (Sekiya et al., 1999; Kim et al.,
2000). PLC-β4 is expressed primarily in retina and
cerebellum (Kim et al., 1998). The expression of PLC-
β2, however, is largely confined to hematopoietic line-
age with a minor immunoreactivity in other tissues (Park
et al., 1992; Jiang et al., 1997; Sekiya et al., 1999). The
difference in tissue distributions reflects that the expre-
ssion of each PLC-β subtype could be regulated differ-
ently. In this report, we have isolated and characterized
the genomic clones including 5'-upstream region of
PLC-β2 gene.
 
Materials and Methods
Isolation of genomic clone of 5'-upstream region of
PLC-β2 gene and construction of deletion mutants
for the region
A human genomic library in EMBL3 (Clonetech, Palo
Alto, CA) was screened with a 600 bp Acc1 fragment of
the human PLC-β2 cDNA as a probe (Park et al., 1992).
One positive clone was rescreened and Southern-
blotted with oligonucleotide probe (5' AATCTAGTTGC-
TCTTATAGCCCCTG 3') located in 5'-untranslated region
of the cDNA. Two fragments, an 810 bp AvaI fragment
(-636/+175) and an 805 bp BanI fragment (−621/+185),
were selected and subcloned into an EcoRV site of
pKS+ (Stratagene, La Jolla, CA) named pB2A2 and pB2B5
respectively. Restriction enzyme mapping and nucleo-
tide sequencing confirmed the correct inserts. A SalI-
SmaI fragment (850 bp) of pB2A2 was subcloned into
SalI-SmaI cut of E1b-TATA chloramphenicol acetyl trans-
ferase (CAT), resulting in pA2-636CAT. Nested deletion
using ExoIII and S1 nuclease (Promega, Madison, WI)
after digestions with SphI and ClaI was carried out to
produce 5'-deletion mutants of the cloned region. The
exact deletion was determined by dideoxy termination
sequencing.
Cell Culture, transient transfection and CAT assays
Daudi (human Burkitt lymphoma) cells (1-2 × 107) were
electroporated with 20 µg of plasmid DNA as described
(Lee et al., 1997). After 48 hrs of incubation, the cells
were harvested and soluble, cytosolic extract was pre-
pared by three cycles of freezing-thawing. The CAT
activities were assayed with 100-150 µg of the extracts
as described previously (Lee et al., 1997).
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Primer extension analysis
The primer used for extension was a synthetic oligo-
nucleotide, corresponding to the antisense sequence
(+106/+86) of the nucleotide in human PLC-β2 gene.
The labeled primer was mixed with 50 µg of total RNA
extracted from Daudi cells and coprecipitated with cold
ethanol. The pellet was dissolved in 20 µl of hybridi-
zation buffer (80% formamide, 300 mM sodium citrate,
pH 6.4, 300 mM sodium acetate, pH 6.4, and 1 mM
EDTA). The mixture was heated for 10 min at 75oC,
incubated at 37oC overnight, then ethanol-precipitated.
cDNA was prepared from the hybrids as described
elsewhere (Lee et al., 1997). Extension was performed
at 40oC for 75 min and the reaction was stopped by
addition of 1 ml of 0.5 M EDTA and 1 ml of DNase-free
RNase (Boeringer Mannheim, Mannheim, Germany),
incubated for 30 min at 37oC, and extracted with phenol-
chloroform. The elongated product was analyzed on 6%
polyacrylamide sequencing gel with sequencing reac-
tion products of the same primer. 
S1 nuclease mapping analysis
The probe used for S1 nuclease protection was PvuII/
AvaI fragment (−210/+165) prepared from pB2B5. AvaI
site of pB2B5 was 5' end-labeled with [γ-32P]ATP and
purified through agarose gel electrophoresis. The probe
was hybridized with total RNA (100 µg) from Daudi cells
in 40 µl of S1 hybridization solution (20 mM Tris, pH 7.4,
400 mM NaCl, 1 mM EDTA, 0.4% SDS, 75% formamide),
heated for 15 min at 75oC and incubated at 49oC over-
night. After addition of S1 mixture (salmon sperm DNA
2 mg 3 M NaCl, 33.2 mM ZnSO4, 200 mM sodium acetate,
pH 4.5, 200 units of S1 nuclease), the mixture was
incubated at 37oC for 1 hr and the reaction was stopped
by phenol-chloroform extraction. The protected fragment
was fractionated on 6% polyacrylamide denaturing gel.
Gel mobility shift assay
For preparation of cell extract, 5 × 107 Daudi cells were
suspended in a extraction buffer (20 mM Hepes, pH 7.9,
350 mM NaCl, 1 mM PMSF, 10 µg/ml leupeptin, 1 µg/
ml aprotinin), were placed on ice for 10 min, and centri-
fuged. The resulting supernatant was collected and
stored -70oC until use. The probes for gel shift assay
were synthetic oligonucleotides, NS1 (−636/−606) and
NS2 (−610/−587), and they were end-labeled with [α-
32P]dCTP by Klenow. The unreacted nucleotides were
separated by gel filtration chromatography on Sepharose
G-25 column. For binding assays, a various amounts of
Daudi whole cell extracts were preincubated with 1 µg
of poly (dI-dC) in the presence or absence of the indi-
cated unlabeled DNA as a competitor for 5 min on ice
in 13 µl of binding buffer (12 mM Hepes, pH, 7.9, 4 mM
Tris, pH 7.9, 60 mM KCl, 12% glycerol, 1 mM EDTA, 1
mM DTT). Labeled probe (~40,000 cpm) was added to
the reaction mixture and incubated at 15oC for 25 min.
The resulting products were resolved on 5% polyacryl-
amide gel in Tris-borate-EDTA buffer.
Results
Cloning and sequence analysis of the 5'-flanking
region of the PLC-β2 gene
The 5'-flanking region of the PLC-β2 gene was cloned
by screening a human genome library. The schematic
diagram for the cloned region was illustrated in Figure 1.
An AvaI fragment was subcloned into pKS+ vector. DNA
sequencing revealed that the Ava1 fragment contains
636 bp of 5'-upstream region and 175 bp of 5'-untrans-
lated region. To identify the site for transcription initi-
ation, we carried out S1 nuclease mapping and primer
extension analyses. The probe used for S1 nuclease
mapping was the PvuII/AvaI fragment (Figure 1 and
Figure 2A). When this fragment was hybridized to the
total RNA from Daudi cells, 175 nucleotides of Daudi
RNA was protected from the S1 nuclease, indicating the
transcription initiation site is located at 175 bp-upstream
of the AvaI site. The transcription start site was confirm-
ed by primer extension analysis using end-labeled
primer oligo A, which is denoted with underline in Figure
5. The extension products generated by reverse tran-
scription from the labeled primer, oligo A, were 144 and
151 nucleotides long (Figure 2C) suggesting there are
two transcription start sites. Since the sequence of oligo
A is located at 31 nucleotides upstream of AvaI site of
the probe for S1 nuclease mapping, 144 nucleotides
fragment was identified as a product from major tran-
scription start site. The major transcription site, then, is
located at 284 nucleotides upstream from the translation
initiation codon. The transcription start site is denoted by
the arrowhead in Figure 2C and shown by +1 in Figure 5.
Regulatory region responsible for transcription of
PLC-β2 gene
The 5'-upstream sequence near the transcription start
site lacks both TATA box and typical initiator sequence
(Smale and Baltimore, 1989). Interestingly the proximal
region of 5'-upstream region of PLC-β2 (−100 to −1) is
GC-rich (69%) and has multiple GC-boxes (Blake et al.,
1990). A number of potential regulatory elements exist
in this region (Table 1). To determine whether the 5'-
upstream region of the human PLC-β2 gene has tran-
scriptional regulatory region, series of deletion mutants
of the region were generated. The resulting promoter/
reporter gene constructs were transiently transfected in
human Daudi Burkitt lymphoma cells and CAT activities
were measured. The effects of deletions were diagram-
ed in Figure 3. There was a dramatic increase of CAT
activity in the deletion of −636 to −588 bp in the 5'-
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Figure 1. Schematic diagram of human genomic DNA segment, 5'-upstream region of PLC-β2. The top, thick line indicates a 600 bp cDNA probe. The
oligonucleotide probe for screening genomic clone is described in bottom, thick line. Partial restriction map is described in the expanded view of the 811 bp
AvaI fragment. Arrow indicates the transcription start site of the gene.
Figure 2. Identification of the transcription start site of the human PLC-β2 gene. A. The restriction map of pB2B5. B. S1 nuclease mapping analysis. PvuII/
AvaI fragment described in A was used as a probe. Lane 1, control products with yeast tRNA, lane 2, the protected fragments with Daudi RNA, lane 3, the
S1 probe. Protected fragments containing 175 bases are indicated by arrow. C. Primer extension analysis, 32P-labeled oligo A was hybridized to 50 µg of total
RNA from Daudi cells. The dideoxy-sequencing ladder of the same strand is shown. The arrowhead indicates a putative major transcription start site.
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upstream region, suggesting that there is a negative
regulatory element in the deletion. Further deletion up to
−98 bp maintained the promoter activity comparable to
that of pA2-588 CAT. On the contrary, there was a sharp
drop of CAT activity between −93 and −13 bp, implying
the existence of a positive regulatory element in that
deletion. Further removal to +169 bp, then, having no
transcription start site, abrogated the promoter activity
completely. These results indicate that there are one
positive and one negative element in the 5'-upstream
region of the PLC-β2 gene. The negative regulatory
region of PLC-β2 gene was designated as B2NR, ex-
tending from −636 to −588, and the positive regulatory
element as B2PR is located between −98 and −13 bp 5'-
upstream of the gene.
Identification of putative negative regulator of PLC-
β2 gene
To identify proteins binding to B2NR, gel mobility shift
assay was performed using radiolabeled oligonucleotides,
NS1 (−636/−606) and NS2 (−610/−587). When whole
cell extracts from Daudi cells were incubated with NS1,
a single distinct band appeared (Figure 4). The pres-
ence of 50-fold excess unlabeled NS1 hindered the
complex formation. The NS2 probe produced four dis-
tinct retarded bands (Figure 4B). All bands detected with
NS2 seemed to be specific to the NS2, since 50 fold
excess unlabeled NS2 competed for complex formation.
As shown in Figure 4, NS1 produced one band that
had mobility similar to one of the bands produced by
NS2. To test whether the complexes formed by two
probes were the same identity, the cross-competition
Table 1. Consensus sequences for transcription factors in the 5'-upstream
region of PLC-β2 gene
Putative 
element
Consensus 
sequence
PLC-β2 
sequence Location
AP2 CCCA/CNG/CG/CG/C CCCACCCC −355/−343
−138/−131
CTCF CCCTC CCCTC −244/−240
−185/−181
E2A G/ACAGNTG GCAGGTG −460/−454
Ets-1 G/CA/CGGAA/TGT/C GAGGAAGC
CAGGAAGT
−434/−427
−65/−58
GCF C/GCGC/GC/GC/GC GCGCCGC −617/−610
NF-IL6 TT/GNNGNAAT/G TTGAGAAAG −425/−417
Oct-2 CTCATGA CTCATGA −114/−108
PEA3 AGGAAG/A AGGAAG −433/−428
−78/−73
−64/−59
PuF GGGTGGG GGGTGGG −44/−26
Sp1 G/TG/AGGCG/TG/AG/T GGGGCGGG
GAGGCGGG
−27/−20
−11/−3
TCF-1 C/AAC/AAG CAAAG
CACAG
−503/−499
−154/−150
TCF-2a G/CAGGAAGT/C GAGGAAGC
CAGGAAGT
−434/−427
−45/−38
Potent transcriptional factor binding sites found within 5'-upstream region of
PLC-β2 are listed. Consensus sequences for transcriptional factors were
obtained from Faisst and Meyer (1992).
Figure 3. 5'-deletion mutants of human PLC-β2 gene and the promoter activity. A. Various deletion mutants of the 5'-upstream region of PLC-β2 gene are
shown. Numbers are relative to the transcription start site. These PLC-β2 deleted fragments were fused with the coding region of bacterial chloramphenicol
acetyl transferase (CAT) gene. Twenty µg of each deletion constructs were transfected by electroporation into human Daudi Burkitt lymphoma cells. CAT
activities have been normalized for the β-galactosidase activity produced by co-transfected pCH110 plasmid. B. Corrected activities of each construct are shown
as the percent activity relative to the mean activity of the longest promoter construct. Transfection was repeated at least twice, yielding reproducible results.
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experiment was carried out with the other oligonucleo-
tide as a competitor. Inclusion of excess unlabeled NS2
in the NS1 reaction mixture competed for the complex
formation. But unlabeled NS1 in 50-fold excess did not
compete for the complex formation bound NS2 except
two minor lower bans. These results suggest that
several proteins that bind to this region specifically
recognize B2NR.
Discussion
PLC-β2 gene expression is largely confined to hemato-
poietic lineage (Jiang et al., 1997). Studies of the 5'-
upstream region of PLC-β2 gene might provide a basis
of assessing cis-elements and transcription factors
involved in restricted expression of the gene. Here, we
report the isolation and functional characterization of 5'-
upstream from the AUG codon, which further supported
by the promoter activities of the deletion constructs. The
deletions of upstream region from −13 and downstream
region from −49 abolished the promoter activity almost
completely and suggest the presence of the entry site
for the basic transcriptional machinery between −49 and
−13 and agrees with the suggested transcription initi-
ation site.
The primary sequence around transcription start site
lacks either TATA motif or initiator sequences, but con-
tains multiple GC-rich boxes. Within −100 bp from the
transcription start site, two consensus sequences for
Sp1 are identified, −25 and −11. Analysis of GC-boxes
in the dihydrofolate reductase promoter revealed that
the interactions between at least two of four GC boxes
are required for transcription initiation (Blake et al.,
1990). In addition, in a model system of TATA-lacking
promoters, Sp1 has been shown to mediate transcrip-
tion initiation complex (Pugh and Tjian, 1991). Therefore,
the specificity of selection of transcription start site of
PLC-β2 gene might reside in the GC-boxes. Actually
binding sequences for Sp1 have been identified in the
proximal promoters of many cellular genes including PLC-
β2 gene. In agreement with this suggestion, removal of
downstream region from −49, which resulted in elimi-
nation of Sp1 sites, shut down the promoter activity.
Transfection study with deleted-promoter constructs
revealed that two regulatory regions exist in PLC-β2
gene. A positive regulatory region (−98 to −13), B2PR,
and a negative regulatory region (−636 to −588), B2NR,
were identified. B2NR contains a binding site (5'-GCG-
CCGC-3') for GCF, a suppressor of epidermal growth
factor receptor (EGFR) gene (Kageyama and Pastan,
1989; Beguinot et al., 1995). In B2PR there are many
Figure 4. Gel mobility shift assays. A-C. Labeled fragments, NS1 and NS2, were incubated with the indicated amounts of Daudi whole-cell extracts in the
absence or presence (50-, 100-, and 200-fold molar excess) of competitor as indicated. The samples were run on nondenaturing 5% polyacrylamide gels. D.
The DNA sequence of oligonucleotide of B2NR.
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binding sites for transcription factors such as TCF-2a,
PuF, and TCF-1, which are expressed in specific tissue
types that express the PLC-β2. TCF-1 is expressed in
T-cell specific fashion, which might play a role in the
establishment of the mature T cell phenotypes (van de
Wetering et al., 1991). Also Ets has been reported to be
expressed preferentially in lymphoid cells (Gunther et al.,
1990). Although the putative binding sites for transcrip-
tion factors were identified in the regulatory regions of
PLC-β2 gene, further characterization should be needed
to elucidate the involvement of these factors in the
transcriptional regulation of PLC-β2 gene. 
The binding proteins for B2NR were identified by gel
mobility shift assays. NS2 formed four protein-nucleo-
tide complexes and cross-competition analysis revealed
that at least two of the complexes were not competed
with NS1. These results suggest that there are different
binding proteins recognize this B2NR region and the
repression of the transcription of PLC-β2 gene might be
conferred by the interaction of these DNA-binding pro-
teins.
From these results, it seems likely that the transcrip-
tion of PLC-β2 gene might be under control of both
positive and negative regulatory mechanisms and char-
acterization of the transcription factors which bind to the
regulatory regions would be the promising way to under-
stand the regulation of PLC-β2 expression. 
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Figure 5. The nucleotide sequence of the 5'- and 3'-flanking region of the transcription start site of human PLC-β2. 5'-upstream region of the human PLC-
β2 in Figure 1 was sequenced. The transcription start point identified by primer extension analysis is marked as +1. Various possible transcription factor-binding
sites are underlined. Underline (oligo A) indicates the oligonucleotide probe used for primer extension analysis. 
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